删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell c

本站小编 Free考研考试/2022-01-01

Leilei Zhenga, #,
Zitong Zhaoa, #,
Lulu Rongb,
Liyan Xueb,
Yongmei Songa
aState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
bDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

More InformationCorresponding author: E-mail address: xueliyan2003@126.com (Liyan Xue);E-mail address: symlh2006@163.com (Yongmei Song)
Received Date: 2019-07-22
Accepted Date:2019-10-17
Rev Recd Date:2019-09-21
Available Online: 2019-11-14 Publish Date:2019-10-20




Abstract
Ras-association (RA) domain family number 6 (RASSF6) is a member of the Ras-association domain protein family. It is epigenetically inactive and negatively regulates the malignant progression of some tumors. However, its precise role in esophageal squamous cell carcinoma (ESCC) has not been reported. In this study, we performed immunohistochemistry (IHC) assay. The results show that RASSF6 is upregulated in ESCC and that the elevated expression level of RASSF6 is associated with lymph node metastasis and poor survival of ESCC patients. Consistent with the clinical observations, the upregulation of RASSF6 greatly promotes ESCC cell proliferation, migration and invasion as well as the cell cycle transition to G1/S phasein?vitro. According to models in?vivo, the downregulation of RASSF6 considerably inhibits ESCC tumor growth and lung metastasis. Mechanistically, RASSF6 negatively regulates the tumor suppressor tripartite-motif-containing protein 16 (TRIM16) by promoting its ubiquitination-dependent degradation and eventually activates pathways associated with the cell cycle and epithelial-mesenchymal transition (EMT). Together, these results indicate that the RASSF6-TRIM16 axis is a key effector in ESCC progression and that RASSF6 serves as a potential target for the treatment of ESCC.
Keywords: Esophageal squamous cell cancer,
RASSF6,
Cell cycle,
EMT,
TRIM16



PDF全文下载地址:

http://www.jgenetgenomics.org/article/exportPdf?id=8c9c12c1-be1a-4c0c-a5d1-67b38d05944a&language=en
相关话题/RASSF6TRIM16 promotes proliferation